Higher Medtech Fees In Philippines Will Support Ongoing Regulatory Improvements
Executive Summary
Medtech regulatory fees in the Philippines are being increased for the first time since 2001. The country's FDA says the new fees will support quality improvements.
You may also be interested in...
Asia Reg Roundup: Philippines Sets Short Reg System Deadline, Vietnam Defers, Malaysia Extends
New regulatory systems for devices are proliferating in the ASEAN and South-East Asia region. Some have set short compliance deadlines that have turned out to be unworkable. Will the Philippines, which in January issued an Administrative Order establishing a new risk-based regulatory system, suffer the same fate? Medtech Insight discussed the issue with local regulatory experts Jack Wong and May Ng.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.